Skip to main content
. Author manuscript; available in PMC: 2011 Jul 15.
Published in final edited form as: Biochem Pharmacol. 2010 Mar 30;80(2):197–204. doi: 10.1016/j.bcp.2010.03.023

Fig. 4.

Fig. 4

Loss of one or both ahr alleles does not alter the blood pressure responses to acute exposure to an alpha adrenergic receptor blocker, prazosin, or a ganglionic blocker, hexamethonium. MAP prior to (basal) and during 30 min immediately after ip injection of (A) 1.0 µg/g prazosin or (B) 30.0 µg/g hexamethonium of male ahr+/+, ahr+/−, and ahr−/− mice (n=6–7/genotype). Data represent mean ± SEM and were analyzed by repeated measures two-way ANOVA, using post hoc Holm-Sidak comparisons, *p < 0.05 compared to ahr+/+ and †p < 0.05 compared to ahr+/− within the same treatment group; #p < 0.05 compared to untreated, basal MAP of the same genotype.